NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
5.30
+2.35 (79.66%)
At close: Dec 19, 2025, 4:00 PM EST
5.44
+0.14 (2.64%)
After-hours: Dec 19, 2025, 8:00 PM EST

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $667.86 million as of December 19, 2025. Its market cap has increased by 23,752.03% in one year.

Market Cap
667.86M
Enterprise Value
666.52M
1-Year Change
23,752.03%
Ranking
Category
Stock Price
$5.30

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has increased from $76.50M to $667.86M, an increase of 773.02%. That is a compound annual growth rate of 12.67%.

History

DateMarket Cap% Change
Dec 19, 2025667.90M22,931.03%
Dec 31, 20242.90M123.08%
Dec 29, 20231.30M-63.89%
Dec 30, 20223.60M-78.70%
Dec 31, 202116.90M-41.92%
Dec 31, 202029.10M62.57%
Dec 31, 201917.90M35.61%
Dec 31, 201813.20M-77.70%
Dec 29, 201759.20M18.64%
Dec 30, 201649.90M612.86%
Dec 31, 20157.00M-78.46%
Dec 31, 201432.50M-32.85%
Dec 31, 201348.40M43.62%
Dec 31, 201233.70M-11.32%
Dec 30, 201138.00M-1.81%
Dec 31, 201038.70M-19.21%
Dec 31, 200947.90M118.72%
Dec 31, 200821.90M-72.59%
Dec 31, 200779.90M4.44%
Oct 26, 200776.50M-
View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company932.80B
Johnson & Johnson506.75B
AbbVie396.44B
UnitedHealth Group300.40B
AstraZeneca281.50B
Novartis AG260.63B
Merck & Co.246.17B
Abbott Laboratories220.33B
Market Cap Rankings